Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
Rothenberg, M L, Eckardt, J R, Kuhn, J G, Burris, 3rd, H A, Nelson, J, Hilsenbeck, S G, Rodriguez, G I, Thurman, A M, Smith, L S, Eckhardt, S G, Weiss, G R, Elfring, G L, Rinaldi, D A, Schaaf, L J, Von Hoff, D D
Published in Journal of clinical oncology (01.04.1996)
Published in Journal of clinical oncology (01.04.1996)
Get more information
Journal Article
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation
Rinaldi, D A, Burris, H A, Dorr, F A, Woodworth, J R, Kuhn, J G, Eckardt, J R, Rodriguez, G, Corso, S W, Fields, S M, Langley, C
Published in Journal of clinical oncology (01.11.1995)
Published in Journal of clinical oncology (01.11.1995)
Get more information
Journal Article
A phase I evaluation of multitargeted antifolate (MTA, Ly231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation
RINALDI, D. A, KUHN, J. G, MASCORRO, D, ABRAHAMS, T, VON HOFF, D. D, BURRIS, H. A, DORR, F. A, RODRIGUEZ, G, ECKHARDT, S. G, JONES, S, WOODWORTH, J. R, BAKER, S, LANGLEY, C
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies
HAMMOND, L. A, ECKARDT, J. R, VON HOFF, D. D, ROWINSKY, E. K, BAKER, S. D, ECKHARDT, S. G, DUGAN, M, FORRAL, K, REIDENBERG, P, STATKEVICH, P, WEISS, G. R, RINALDI, D. A
Published in Journal of clinical oncology (01.08.1999)
Published in Journal of clinical oncology (01.08.1999)
Get full text
Journal Article
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
Rothenberg, M. L., Sharma, A., Weiss, G. R., Villalona-Calero, M. A., Eckardt, J. R., Aylesworth, C., Kraynak, M. A., Rinaldi, D. A., Rodriguez, G. I., Burris, H. A., Eckhardt, S. G., Stephens, C. D., Forral, K., Nicol, S. J., Von Hoff, D. D.
Published in Annals of oncology (01.07.1998)
Published in Annals of oncology (01.07.1998)
Get full text
Journal Article
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
Rothenberg, M. L., Kuhn, J. G., Schaaf, L. J., Rodriguez, G.I., Eckhardt, S. G., Villalona-Calero, M. A., Rinaldi, D. A., Hammond, L. A., Hodges, S., Sharma, A., Elfring, G. L., Petit, R. G., Locker, P. K., Miller, L. L., von Hoff, D. D.
Published in Annals of oncology (01.11.2001)
Published in Annals of oncology (01.11.2001)
Get full text
Journal Article
Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion
Burris, 3rd, H A, Awada, A, Kuhn, J G, Eckardt, J R, Cobb, P W, Rinaldi, D A, Fields, S, Smith, L, Von Hoff, D D
Published in Anti-cancer drugs (01.08.1994)
Published in Anti-cancer drugs (01.08.1994)
Get more information
Journal Article
A phase I trial of gemcitabine and infusional 5-fluorouracil (5-FU) in patients with refractory solid tumors: Louisiana Oncology Associates protocol no. 1 (LOA-1)
Rinaldi, D A, Lormand, N A, Brierre, J E, Cole, J L, Stagg, M P, Fontenot, M F, Buller, E J, Rainey, J M
Published in American journal of clinical oncology (01.02.2000)
Published in American journal of clinical oncology (01.02.2000)
Get more information
Journal Article
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies
SHAFFER, D. W, SMITH, L. S, VON HOFF, D. D, BURRIS, H. A, CLARK, G. M, ECKARDT, J. R, FIELDS, S. M, WEISS, G. R, RINALDI, D. A, BOWEN, K. J, KUHN, J. G
Published in Cancer research (Chicago, Ill.) (15.12.1993)
Get full text
Published in Cancer research (Chicago, Ill.) (15.12.1993)
Journal Article
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
von der Maase, H, Hansen, S W, Roberts, J T, Dogliotti, L, Oliver, T, Moore, M J, Bodrogi, I, Albers, P, Knuth, A, Lippert, C M, Kerbrat, P, Sanchez Rovira, P, Wersall, P, Cleall, S P, Roychowdhury, D F, Tomlin, I, Visseren-Grul, C M, Conte, P F
Published in Journal of clinical oncology (10.08.2023)
Published in Journal of clinical oncology (10.08.2023)
Get full text
Journal Article
Phase II trial of docetaxel for cholangiocarcinoma
Pazdur, R, Royce, M E, Rodriguez, G I, Rinaldi, D A, Patt, Y Z, Hoff, P M, Burris, H A
Published in American journal of clinical oncology (01.02.1999)
Published in American journal of clinical oncology (01.02.1999)
Get more information
Journal Article
A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea
RODRIGUEZ, G. I, KUHN, J. G, WEISS, G. R, HILSENBECK, S. G, ECKARDT, J. R, THURMAN, A, RINALDI, D. A, HODGES, S, VON HOFF, D. D, ROWINSKY, E. K
Published in Blood (01.03.1998)
Published in Blood (01.03.1998)
Get full text
Journal Article
A randomized phase I study of oral etoposide with or without granulocyte-macrophage colony-stimulating factor for the treatment of patients with advanced cancer
Weiss, G R, Shaffer, D W, DeMoor, C, Rinaldi, D A, Rodriguez, G I, Eckardt, J R, Stephens, C, Von Hoff, D D
Published in Anti-cancer drugs (01.06.1996)
Published in Anti-cancer drugs (01.06.1996)
Get more information
Journal Article
Outcome of elderly (≥70 years) non-small cell lung cancer (NSCLC) patients on a multicenter, phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C)
Ramalingam, S., Perry, M. C., Larocca, R. V., Rinaldi, D. A., Gable, P., Tester, W. J., Belani, C. P.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
A phase I trial of weekly gemcitabine (GEM), administered as a constant dose-rate infusion, and docetaxel (DOC) in patients with advanced solid tumors (LOA-8)
Rinaldi, D. A., Lormand, N. A., Rainey, J. M., Brierre, J. E., Cole, J. L., Roden, K. B.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A multicenter, phase III randomized trial for stage IIIB/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel
Belani, C. P., Larocca, R. V., Rinaldi, D. A., Tester, W. J., Gable, P. S., Perry, M. C.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase I trial of weekly gemcitabine (GEM), administered as a constant dose-rate infusion, and docetaxel (DOC) in patients with advanced solid tumors (LOA-8)
Rinaldi, D. A., Lormand, N. A., Rainey, J. M., Brierre, J. E., Cole, J. L., Roden, K. B.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article